BioSpace News Archive

Health technology leader Philips recognized as Clarivate Top 100 Global Innovator

Royal Philips, a global leader in health technology, has been included in the 2024 Clarivate Top 100 Global Innovator™ list.

March 6, 2024
·
3 min read
Biotech Beach

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029

Tandem Diabetes Care, Inc. announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

March 6, 2024
·
13 min read
Business

Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, will publish its 2023 financial results on March 14, 2024, at 7.30am CET.

March 6, 2024
·
4 min read
Genetown

Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals

Sosei Group Corporation announces that Formosa Pharmaceuticals, Inc. has received approval from the US Food & Drug Administration for clobetasol propionate ophthalmic suspension 0.05%, for the treatment of post-operative inflammation and pain following ocular surgery.

March 6, 2024
·
3 min read
Medivir to present at Swiss Nordic Bio in Zürich on March 7

Medivir AB announces that the company will participate at the Swiss Nordic Bio conference on March 7, 2024.

March 6, 2024
·
1 min read
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®

Calliditas Therapeutics AB announced that the FDA has granted an orphan drug exclusivity period of seven years for TARPEYO®, expiring in December 2030 based on when the company obtained full approval with a new indication for this drug product.

March 6, 2024
·
1 min read
Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting

Medigene AG will present a poster at the American Association for Cancer Research Annual Meeting 2024 taking place from April 5-10, 2024 in San Diego, USA as well as an oral presentation at the ELRIG-Forum 2024 to be held in Darmstadt, Germany on March 7, 2024.

March 6, 2024
·
5 min read
Latest Updates of Viva Biotech’s Portfolio Companies

Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development.

March 6, 2024
·
9 min read
BioMidwest

Cingulate to Attend DCAT Week 2024 in New York City

Cingulate Inc. announced that it will be attending DCAT Week March 18-21, 2024, in Midtown Manhattan.

March 6, 2024
·
7 min read
Enterome Announces Upcoming Presentation on OncoMimics™ Approach to Cancer Immunotherapy at the AACR Annual Meeting 2024

Enterome announced that data on its novel OncoMimics™ approach to cancer immunotherapy will be presented in a poster at the upcoming American Association of Cancer Research Annual Meeting, taking place April 5-10 in San Diego, California.

March 6, 2024
·
3 min read